Bio-Techne Corporation (TECH) has seen a range of significant financial activities the previous fiscal year. These include the company's declaration of dividends, strong Q4 2024 results, the sale and purchasing of its shares by various investment management firms such as
William Blair Investment Management LLC and
National Bank of Canada FI.
Bio-Techne has also been a regular participant at investor healthcare conferences, where it presents its latest capabilities, goals, or achievements. Furthermore, the company has established a new distribution agreement with
Thermo Fisher Scientific, invested in
Spear Bio, developed a next-generation high throughput Simple Western system, and launched its MauriceFlex™ system at the annual ASMS conference.
Bio-Techne also announced a partnership with
Nikon Instruments Inc to expand access to innovative spatial biology services. Meanwhile, it has also surpassed 10,000 peer-reviewed publications citing their RNAscope Technology, indicating the vast recognition and relevance of its products in the biotech sector. Acquisitions also made the headlines, as the company announced plans to acquire
Lunaphore and other significant companies. Lastly,
Bio-Techne's board appoints new members and positions, indicative of the company’s progressive leadership and strategic decisions.
Bio-Techne Corp TECH News Analytics from Sun, 13 Jul 2014 07:00:00 GMT to Sun, 15 Sep 2024 11:04:36 GMT -
Rating 7
- Innovation 5
- Information 9
- Rumor 4
